Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry

Hyperleptinemia Exacerbates High-Fat Diet-Mediated Atrial Fibrosis and Fibrillation

(2017) AKIRA FUKUI et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?

(2017) Marco Proietti et al.   STROKE

The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden

(2016) Giuseppe Boriani et al.   EUROPACE

The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial

(2016) Roopinder K. Sandhu et al.   EUROPEAN HEART JOURNAL

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: Characteristics and prognostic implications

(2016) Konstantinos C. Siontis et al.   HEART RHYTHM

Stroke prevention in atrial fibrillation

(2016) Ben Freedman et al.   LANCET

Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood

(2016) Gilad Twig et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation

(2016) Giuseppe Boriani et al.   VASCULAR PHARMACOLOGY

Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta‐Analysis and Systematic Review

(2016) Wengen Zhu et al.   Journal of the American Heart Association

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men

(2016) Jonathan P. Piccini et al.   JAMA Cardiology

Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry

(2015) Giuseppe Boriani et al.   AMERICAN JOURNAL OF MEDICINE

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

(2015) Gregory Y.H. Lip et al.   EUROPACE

Obesity and cardiovascular disease: friend or foe?

(2015) Seong Hwan Kim et al.   EUROPEAN HEART JOURNAL

Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort

(2015) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Body mass index predicts major bleeding risks in patients on warfarin

(2015) Adedotun A. Ogunsua et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation

(2015) Keitaro Senoo et al.   STROKE

The Heart Failure Overweight/Obesity Survival Paradox

(2015) Amanda R. Vest et al.   JACC-Heart Failure

Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation

(2014) Gregory Y.H. Lip et al.   EUROPACE

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation

(2014) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Body Mass Index and Adverse Events in Patients with Incident Atrial Fibrillation

(2013) Thure Filskov Overvad et al.   AMERICAN JOURNAL OF MEDICINE

Global Gender Disparities in Obesity: A Review

(2012) Rebecca Kanter et al.   Advances in Nutrition

Influence of Obesity on Outcomes in Atrial Fibrillation: Yet Another Obesity Paradox

(2010) Apurva O. Badheka et al.   AMERICAN JOURNAL OF MEDICINE

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

(2009) Prospective Studies Collaboration   LANCET